1. Home
  2. UCTT vs PBLS Comparison

UCTT vs PBLS Comparison

Compare UCTT & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ultra Clean Holdings Inc.

UCTT

Ultra Clean Holdings Inc.

N/A

Current Price

$45.98

Market Cap

3.1B

Sector

Technology

ML Signal

N/A

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$28.56

Market Cap

3.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UCTT
PBLS
Founded
1991
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.4B
IPO Year
2004
2026

Fundamental Metrics

Financial Performance
Metric
UCTT
PBLS
Price
$45.98
$28.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
7
Target Price
★ $106.00
$41.00
AVG Volume (30 Days)
★ 1.5M
1.0M
Earning Date
10-27-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.65
N/A
Revenue
★ $1,734,500,000.00
N/A
Revenue This Year
$35.00
N/A
Revenue Next Year
$39.86
$288.07
P/E Ratio
$73.57
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$21.49
$22.66
52 Week High
$144.22
$42.49

Technical Indicators

Market Signals
Indicator
UCTT
PBLS
Relative Strength Index (RSI) 41.85 48.47
Support Level $43.96 $26.42
Resistance Level $58.39 $28.48
Average True Range (ATR) 4.18 2.08
MACD 0.91 0.32
Stochastic Oscillator 42.04 53.86

Price Performance

Historical Comparison
UCTT
PBLS

About UCTT Ultra Clean Holdings Inc.

Ultra Clean Holdings Inc, through its subsidiaries, manufactures and supplies production tools, modules, and subsystems for the semiconductor capital equipment industry. The product includes precision robotic solutions, gas delivery systems, and a variety of industrial and automation production equipment products; subsystems include wafer cleaning subsystems, chemical delivery modules, top-plate assemblies, frame assemblies, and process modules. Its customer base includes firms in the semiconductor capital equipment industry, medical, energy, industrial, flat panel, and research equipment industries. It has two segments: Products and Services. Its principal markets are the Americas, Asia Pacific, and EMEA.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: